StockClub

AGIO

AGIOAgios Pharmaceuticals, Inc.$ --
Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc.

AGIO

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
20M USD
YoY +86.1%
Operating Income
-122M USD
YoY +2.8%
Net Income
-108M USD
YoY -11.9%
EPS
-1.85$
YoY -9.5%

Revenue

$54M
FY2024 Q1$8.2M
$8.2M
Q1
FY2024 Q2$16.8M
$16.8M
Q2
FY2024 Q3$25.8M
$25.8M
Q3
FY2024 Q4$36.5M
$36.5M
Q4
FY2025 Q1$8.7M
$8.7M
Q1
FY2025 Q2$21.2M
$21.2M
Q2
FY2025 Q3$34.1M
$34.1M
Q3
FY2025 Q4$54M
$54M
Q4
Actual
+$17.5M (+48.0%)

Net Income

$-412.8M
FY2024 Q1$-81.5M
$-81.5M
Q1
FY2024 Q2$-177.7M
$-177.7M
Q2
FY2024 Q3$770.2M
$770.2M
Q3
FY2024 Q4$673.7M
$673.7M
Q4
FY2025 Q1$-89.3M
$-89.3M
Q1
FY2025 Q2$-201.3M
$-201.3M
Q2
FY2025 Q3$-304.7M
$-304.7M
Q3
FY2025 Q4$-412.8M
$-412.8M
Q4
Actual
$-1.1B (-161.3%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$0
Est:$199.1M
FY2020MISS
$0
FY2021MISS
Actual:$0
Est:$558,818
FY2021MISS
$0
FY2022BEAT
Actual:$14.2M
Est:$13.9M
FY2022BEAT
$14.2M
FY2023MISS
Actual:$26.8M
Est:$31.3M
FY2023MISS
$26.8M
FY2024BEAT
Actual:$36.5M
Est:$35.2M
FY2024BEAT
$36.5M
FY2025BEAT
Actual:$54M
Est:$46.1M
FY2025BEAT
$54M

Analyst Estimates